B.C.’s functional and psychedelic mushroom industry is having a shroom boom
Antidepressants are often ineffective and can even interfere with cancer treatment drugs.
“Psychedelics are proving to not conflict with the cancer drug and are more effective than normal antidepressants generally,” according Frank Lane, director of Albert Labs.
That’s why the BC-based company wants to bring a psilocybin treatment for cancer patients to European markets.
Albert Labs is expected to begin trading on the CSE early next year under the ticker ’ABRT’.
